Control and enhancement of permselectivity of membrane‐based microcapsules for favorable biomolecular transport and immunoisolation

The success of membrane-based, cell-encapsulating microcapsules depends on the membrane permselectivity that provides efficient inward transport of nutrients, therapeutic protein egress, and complete exclusion of immunoglobulins. Microcapsules with a calcium crosslinked alginate core and a genipin-crosslinked chitosan alginate (GCA) were prepared with good control over size, membrane thickness and density. Importantly, in this study, we report a novel approach of using three relevant biomolecules and investigating the effects of the membrane characteristics (thickness and density) and microcapsule size on biomolecular mass transport across the GCA microcapsules using mathematical models based on a balance of the chemical potential. Scaling analysis was used to interrelate the membrane thickness, chitosan–alginate reaction rate constant, and diffusion coefficient. The resistance to diffusion of the three biomolecules increased with membrane density and thickness. Interestingly, swelling in the large microcapsules resulted in an increase in permeability, allowing larger biomolecules (immunoglobulin and carbonic anhydrase) to diffuse more readily. In the case of the smaller biomolecule, vitamin B12, a shorter diffusion path length in smaller microcapsules allowed better ingress. When compared with other microcapsules, the GCA microcapsules possess improved permselectivity for them to allow diffusion of small nutrient molecules and proteins, whereas completely excluding antibodies. Also, these results elucidate the importance of membrane properties and microcapsule size to realize favorable transport of biomolecules. © 2011 American Institute of Chemical Engineers AIChE J, 2011

[1]  Robert Langer,et al.  Coated alginate microspheres : factors influencing the controlled delivery of macromolecules , 1991 .

[2]  J. Lou,et al.  Biologic effect and immunoisolating behavior of BMP-2 gene-transfected bone marrow-derived mesenchymal stem cells in APA microcapsules. , 2007, Biochemical and biophysical research communications.

[3]  Chi-Hwa Wang,et al.  Electrospray in the dripping mode for cell microencapsulation. , 2007, Journal of colloid and interface science.

[4]  C. Djerassi,et al.  Naturally Occurring Oxygen Heterocyclics. IX.1 Isolation and Characterization of Genipin2 , 1960 .

[5]  B. Kulseng,et al.  Poly-L-Lysine Induces Fibrosis on Alginate Microcapsules via the Induction of Cytokines , 2001, Cell transplantation.

[6]  B. Kulseng,et al.  Microencapsulation of Cells Producing Therapeutic Proteins: Optimizing Cell Growth and Secretion , 2002, Cell transplantation.

[7]  P. Chang,et al.  Development of small alginate microcapsules for recombinant gene product delivery to the rodent brain , 2002, Journal of biomaterials science. Polymer edition.

[8]  Chi‐Hwa Wang,et al.  Electric field controlled electrospray deposition for precise particle pattern and cell pattern formation , 2010 .

[9]  P. Chang,et al.  Enhancement of myoblast microencapsulation for gene therapy. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[10]  R. Timpl,et al.  Local endostatin treatment of gliomas administered by microencapsulated producer cells , 2001, Nature Biotechnology.

[11]  S. Prakash,et al.  Genipin cross-linked alginate-chitosan microcapsules: membrane characterization and optimization of cross-linking reaction. , 2006, Biomacromolecules.

[12]  H. Sung,et al.  In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. , 1999, Journal of biomaterials science. Polymer edition.

[13]  R. Lanza,et al.  Encapsulated cell technology , 1996, Nature Biotechnology.

[14]  Anthony Atala,et al.  Continuous release of endostatin from microencapsulated engineered cells for tumor therapy , 2001, Nature Biotechnology.

[15]  Yubing Xie,et al.  Insight into permeability of protein through microcapsule membranes , 2006 .

[16]  S. Prakash,et al.  Novel multi-layer APPPA microcapsules for oral delivery: preparation condition, stability and permeability. , 2009, Indian journal of biochemistry & biophysics.

[17]  J. Miyazaki,et al.  A novel cytomedical vehicle capable of protecting cells against complement. , 2003, Biochemical and biophysical research communications.

[18]  J. Brash,et al.  Encapsulation of various recombinant mammalian cell types in different alginate microcapsules. , 1998, Journal of biomedical materials research.

[19]  S. Prakash,et al.  Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy , 2007, Cell Biochemistry and Biophysics.

[20]  H. Drexler,et al.  Cell-based therapy for heart failure , 2006, Current opinion in cardiology.

[21]  F. Lim,et al.  Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.

[22]  J. Remon,et al.  Host Reaction against Empty Alginate‐polylysine Microcapsules. Influence of Preparation Procedure , 1993, The Journal of pharmacy and pharmacology.

[23]  M. Nowakowska,et al.  pH-sensitive genipin-cross-linked chitosan microspheres for heparin removal. , 2008, Biomacromolecules.

[24]  N. A. Burke,et al.  Core-cross-linked alginate microcapsules for cell encapsulation. , 2009, Biomacromolecules.

[25]  Takao Yamamoto,et al.  Permeability of azo-dye through poly(urea-urethane) microcapsule membrane , 2003 .

[26]  H. D. H. Stöver,et al.  Cross-linked microcapsules formed from self-deactivating reactive polyelectrolytes. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[27]  A. Urbanska,et al.  Investigation of a New Microcapsule Membrane Combining Alginate, Chitosan, Polyethylene Glycol and Poly-L-Lysine for Cell Transplantation Applications , 2005 .

[28]  P. Chang,et al.  Permeability of alginate microcapsules to secretory recombinant gene products , 1996, Biotechnology and bioengineering.

[29]  S. Prakash,et al.  Reaction of chitosan with genipin and its fluorogenic attributes for potential microcapsule membrane characterization. , 2005, Journal of biomedical materials research. Part A.

[30]  Gorka Orive,et al.  History, challenges and perspectives of cell microencapsulation. , 2004, Trends in biotechnology.

[31]  B. R. Hsu,et al.  Impact of cracks in alginate microcapsules on the survival of pancreatic islets. , 2003, Transplantation proceedings.

[32]  T. Chang,et al.  Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats , 1996, Nature Medicine.

[33]  D. Hunkeler,et al.  New Microcapsules Based on Oligoelectrolyte Complexation , 1999, Annals of the New York Academy of Sciences.

[34]  M. Peschanski,et al.  Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease , 1997, Nature.